Abstract
RecentnĂ onemocnÄnĂ COVID-19 pĹinĂĄĹĄĂ moĹžnĂŠ rizikovĂŠ faktory ĹžilnĂho tromboembolismu a horĹĄĂ klinickĂ˝ prĹŻbÄh u nÄkterĂ˝ch pacientĹŻ mĂĄ spojitost s trombĂłzou. ZatĂmco nĂzkomolekulĂĄrnĂ hepariny jsou zkoumĂĄny s ohledem na vhodnou dĂĄvku, ostatnĂ elementy mohou bĂ˝t uĹžiteÄnĂŠ. SdĂlĂme naĹĄi zkuĹĄenost tĂ˝kajĂcĂ se dvou pacientĹŻ s neoÄekĂĄvanĂ˝m klinickĂ˝m prĹŻbÄhem. © 2020, ÄKS.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
